NCT03381625 Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03376243 EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic Eczema Status COMPLETED Phase NA
NCT03375970 Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis Status UNKNOWN Phase NA
NCT03363854 Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 Status COMPLETED Phase PHASE3
NCT03361215 Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis Status RECRUITING Phase N/A
NCT03356977 A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT03351777 Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis Status UNKNOWN Phase PHASE2
NCT03334435 A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03334422 Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03334396 A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03327116 Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients Status COMPLETED Phase NA
NCT03315611 Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis Status COMPLETED Phase NA
NCT03304470 A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03297502 Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03293030 Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT03269773 Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) Status COMPLETED Phase PHASE3
NCT03260595 A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03257644 A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03257215 Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study Status TERMINATED Phase PHASE4